rubella

42
RUBELLA Dr.T.V.Rao MD

Upload: tumalapalli-venkateswara-rao

Post on 01-Jun-2015

3.703 views

Category:

Health & Medicine


5 download

DESCRIPTION

Rubella

TRANSCRIPT

Page 1: Rubella

RUBELLADr.T.V.Rao MD

Page 2: Rubella

History - Rubella

The Teratogenic property of the infection was documented by an Australian ophthalmologist Norman McAlister Gregg, in 1941

Dr.T.V.Rao MD 2

Page 3: Rubella

Introduction• Rubella, commonly known as German

measles, is a disease caused by Rubella virus. The name is derived from the Latin, meaning

little red. • Rubella is also known as German measles

because the disease was first described by German physicians, Friedrich Hoffmann, in the mid-eighteenth century.

Dr.T.V.Rao MD 3

Page 4: Rubella

What is Rubella

Rubella (German measles) is a disease caused by the rubella virus. Rubella is usually a mild illness. Most people who have had rubella or the vaccine are protected against the virus for the rest of their lives. Because of routine vaccination against rubella since 1970 , rubella is now rarely reported.

Dr.T.V.Rao MD 4

Page 5: Rubella

Rubella( German Measles )

Rubella is also called as 3 day Measles or German Measles.

Family – Togaviridae

Genus - Rubivirus In general belong to

Togavirus group

Page 6: Rubella

Rubella Virus

Rubella virus are ss – RNA virus Diameter 50 – 70 nm Enveloped Spherical Virus carry hem

agglutinin Virus multiply in the

cytoplasm of infected cell.

Page 7: Rubella

Prevailing Genotypes

Dr.T.V.Rao MD 7

Page 8: Rubella

Cause and Transmission• The disease is caused by Rubella virus, a toga

virus that is enveloped and has a single-stranded RNA genome, 60-70nm diameter.

• The virus is transmitted by the respiratory route and replicates in the nasopharynx and lymph nodes.

• The virus is found in the blood 5 to 7 days after infection and spreads throughout the body.

Dr.T.V.Rao MD 8

Page 9: Rubella

Acquired Rubella • Acquired rubella is

transmitted via airborne droplet emission from the upper respiratory tract of active cases.

• The virus may also be present in the urine, feces and on the skin. Dr.T.V.Rao MD 9

Page 10: Rubella

Signs and Symptoms• After an incubation period of 14-21 days,

the primary symptom of rubella virus infection is the appearance of a rash (exanthema) on the face which spreads to the trunk and limbs and usually fades after three days.

• The skin manifestations are called "blueberry muffin lesions."

Dr.T.V.Rao MD 10

Page 11: Rubella

Main Clinical Events

The clinical events occurring in the neonatal age is more important and divided into two major groups

1 Post Natal Rubella 2 Congenital Rubella

Dr.T.V.Rao MD 11

Page 12: Rubella

Features of Rubella Infection

• The rash disappears after a few days with no staining or peeling of the skin.

• Other symptoms include low grade fever, swollen glands (post cervical lymphadenopathy), joint pains, headache, conjunctivitis.

• The swollen glands or lymph nodes can persist for up to a week and the fever rarely rises above 38 oC (100.4 oF).

Dr.T.V.Rao MD 12

Page 13: Rubella

How Adults acquire InfectionAcquired, (i.e. not congenital), rubella is

transmitted via airborne droplet emission from the upper respiratory tract of active cases. The virus may also be present in the urine, feces and on the skin. There is no carrier state: the reservoir exists entirely in active human cases. The disease has an incubation period of 2 to 3 weeks.

Dr.T.V.Rao MD 13

Page 14: Rubella

Clinical findings Malaise Low grade fever Morbilliform rash Rash starts on Face

Extremities Rarely lasts more than 5

days No features of the rash

give clues to definitive diagnosis of Rubella.

Page 15: Rubella

Systemic events of Rubella Infection

Dr.T.V.Rao MD 15

Page 16: Rubella

Rubella during Pregnancy• "Rubella infection in

pregnant women during the first three months of pregnancy may result in the baby being born with birth defects or congenital rubella syndrome

Dr.T.V.Rao MD 16

Page 17: Rubella

Post natal Rubella Occurs in Neonates and

Childhood Adult infection occurs through

mucosa of the upper respiratory tract spread to cervical lymph nodes

Viremia develops after 7 – 9 day Lasts for 13 – 15 days Leads to development of

antibodies The appearance of antibodies

coincides the appearance of suggestive immulogic basis for the rash

In 20 – 50 % cases of primary infections are subclinical

Page 18: Rubella

Congenital Manifestations

Dr.T.V.Rao MD 18

Page 19: Rubella

An Infant Presenting with Congenital Cataract

Dr.T.V.Rao MD 19

Page 20: Rubella

Rubella RashesWhen epidemics

occur with similar features it is more suggestive of Rubella epidemics

Other Enterovirus infections can produce similar manifestations.

Page 21: Rubella

Other manifestations and complications

May produce transient Arthritis, in women in particular.

Serious complications are

Thrombocytopenia Purpura Encephalitis

Page 22: Rubella

Dr.T.V.Rao MD 22

Page 23: Rubella

Immunity - Rubella Antibodies appear in

serum as rash fades and antibody titers raise

Rapid raise in 1 – 3 weeks

Rash in association with detection of IgM indicates recent infection.

IgG antibodies persist for life

Page 24: Rubella

Immunity - Protects

One attack of Rubella infection, protects for life

Immune mothers transfer antibodies to off springs who are in turn are protected for 4 – 6 months.

Page 25: Rubella

Culturing the Virus

The virus can be cultured and adopted to continuous cell lines Rabbit kidney

cells (RK 13 ) and

Vero cells

Page 26: Rubella

Diagnosis of Rubella in Adults

Clinical Diagnosis is unreliableMany viral infections mimic

RubellaSpecific diagnosis of infection

with 1 Isolation of virus 2 Evidence of seroconversion

Dr.T.V.Rao MD 26

Page 27: Rubella

Isolation and Identification of virus

Nasopharyngeal or throat swabs taken 6 days prior or after appearance of rash is a good source of Rubella virus

Using cell cultured in shell vial antigens can be detected by Immunofluresecentet methods

Page 28: Rubella

Serology In Rubella Hemagglutination inhibition

test for Rubella is of Diagnostic significance

ELISA tests are greater importance

A raise in Antibody titers must be demonstrated between two serum samples taken at least 10 days apart.

Or Detection of Rubella specific IgM must be detected in a single specimen.

Page 29: Rubella

Epidemiology

Rubella is world wide in distribution Occurs round the year, Epidemics occur every 20 – 25 years Infection is transmitted by respiratory route The use of Rubella vaccine has now eliminated

both epidemic and endemic Rubella in USA and several developed countries

Dr.T.V.Rao MD 29

Page 30: Rubella

Treatment and PreventionRubella is a mild self limited

illness.No specific treatment or Antiviral

treatment is indicated.However Laboratory proved and

clinically missed Rubella in the Ist 3-4 months of pregnancy is associated with fatal infections.Dr.T.V.Rao MD 30

Page 31: Rubella

Congenital Rubella

• Since the virus can cross the placenta, it can cause Congenital Rubella Syndrome in the newly born.

• Congenital infection may be mild and asymptomatic or severe, causing cataracts, glaucoma, deafness, heart abnormalities, mental retardation or death.

Dr.T.V.Rao MD 31

Page 32: Rubella

Congenital Rubella Syndrome Maternal Viremia with Rubella infection

during pregnancy may result in infection of placenta and fetes.

The growth rate of fetal cells are reduced. Results in fewer number of cells after the

birth. Lead to deranged and hypo plastic organ

development. Results in structural damage and

abnormalitiesDr.T.V.Rao MD 32

Page 33: Rubella

Rubella infection – At various trimesters

Ist trimester infections lead to abnormalities in 85 % of cases. and greater damage to organs

2nd trimester infections lead to defects in 16 % > 20 weeks of pregnancy fetal defects are

uncommon However Rubella infection can also lead to fetal

deaths, and spontaneous abortion. The intrauterine infections lead to viral excretion in

various secretion in new-born upto 12-18 months.

Dr.T.V.Rao MD 33

Page 34: Rubella

Clinical Findings( Congenital Rubella Syndrome )

May be transient effects in infants.

Permanent manifestations may be apparent at birth, become recognized during the first year.

Developmental abnormalities appear during childhood and adolescents. Dr.T.V.Rao MD 34

Page 35: Rubella

Rubella Epidemic• The largest rubella epidemic in the United

States occurred in 1964-1965, and resulted in the birth of an estimated 30,000 infants with congenital rubella syndrome. As many as 85% of pregnant women with clinical rubella delivered babies with congenital rubella. The highest percentage of congenital rubella occurred when the pregnant mothers had rubella during the first trimester

Dr.T.V.Rao MD 35

Page 36: Rubella

Classical Triad of Rubella Classical Triad Cataract Cardiac

abnormalities Deafness Other manifestations Growth retardation Rash Hepatosplenomegaly Jaundice Meningoencephalitis CNS defects lead to moderate to

profound mental retardation

Page 37: Rubella

Other Neurological manifestations Problems in balance Motor skills in

preschool children altered.

A rare complication of Pan encephalitis can occur in second decade with Congenital rubella syndrome may progress to death.

Page 38: Rubella

Diagnosis ofCongenital Rubella Syndrome

Demonstration of Rubella antibodies of IgM in a new born is diagnostic value. As IgM group do not cross the placenta and they are produce in the infected fetus,

Page 39: Rubella

Prevention and Treatment

• Rubella vaccine is given to children at 15 months of age as a part of the MMR (measles-mumps-rubella) immunization.

• The vaccine is live and attenuated and confers lifelong immunity.

• There is no specific treatment for Rubella; management is a matter of responding to symptoms to diminish discomfort. Dr.T.V.Rao MD 39

Page 40: Rubella

Treatment, Prevention, Control

No specific treatment is available

CRS can be prevented by effective immunization of the young children and teenage girls, remain the best option to prevent Congenital Rubella Syndrome.

The component of Rubella in MMR vaccine protects the vaccinated

Page 41: Rubella

MMR Vaccine The MMR vaccine is a mixture of three live

attenuated viruses, administered via injection for immunization against measles, mumps and rubella. It is generally administered to children around the age of one year, with a second dose before starting school (i.e. age 4/5). The second dose is not a booster; it is a dose to produce immunity in the small number of persons (2-5%) who fail to develop measles immunity after the first dose In the United States, the vaccine was licensed in 1963 and the second dose was introduced in the mid 1990s. It is widely used in all National, Universal Immunization programmes Dr.T.V.Rao MD 41

Page 42: Rubella

• Programme Created by Dr.T.V.Rao MD for Medical and Paramedical Students in the

Developing World• Email

[email protected]

Dr.T.V.Rao MD 42